Javascript must be enabled to continue!
Design and evaluation of lornoxicam bilayered tablets for biphasic release
View through CrossRef
The objective of the present investigation was to develop bilayered tablets of lornoxicam to achieve biphasic release pattern. A bilayered tablet, consisting of an immediate and controlled release layer, was prepared by direct compression technique. The controlled release effect was achieved by using various hydrophilic natural, semi synthetic and synthetic controlled release polymers such as xanthan gum, hydroxypropyl methylcellulose (HPMC) and polyethylene oxide (PEO) to modulate the release of the drug. The in vitro drug release profiles showed the biphasic release behavior in which the immediate release (IR) layer containing the lornoxicam was released within 15 minutes, whereas the controlled release (CR) layer controlled the drug release for up to 24 h. All the bilayered tablets formulated have followed the zero order release with non-Fickian diffusion controlled release mechanism after the initial burst release. FTIR studies revealed that there was no interaction between the drug and polymers used in the study. Statistical analysis (ANOVA) showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.05) in the amount of drug released after 24 h from optimized formulations was observed. Based on the release kinetic parameters obtained, it can be concluded that xanthan gum polymer was suitable for providing a biphasic release of lornoxicam.
Title: Design and evaluation of lornoxicam bilayered tablets for biphasic release
Description:
The objective of the present investigation was to develop bilayered tablets of lornoxicam to achieve biphasic release pattern.
A bilayered tablet, consisting of an immediate and controlled release layer, was prepared by direct compression technique.
The controlled release effect was achieved by using various hydrophilic natural, semi synthetic and synthetic controlled release polymers such as xanthan gum, hydroxypropyl methylcellulose (HPMC) and polyethylene oxide (PEO) to modulate the release of the drug.
The in vitro drug release profiles showed the biphasic release behavior in which the immediate release (IR) layer containing the lornoxicam was released within 15 minutes, whereas the controlled release (CR) layer controlled the drug release for up to 24 h.
All the bilayered tablets formulated have followed the zero order release with non-Fickian diffusion controlled release mechanism after the initial burst release.
FTIR studies revealed that there was no interaction between the drug and polymers used in the study.
Statistical analysis (ANOVA) showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.
05) in the amount of drug released after 24 h from optimized formulations was observed.
Based on the release kinetic parameters obtained, it can be concluded that xanthan gum polymer was suitable for providing a biphasic release of lornoxicam.
Related Results
Comparison of Total Hemispherical Reflectance and Emittance Values Between Metformin Extended-Release Tablets Stored Under Ambient and Stress Conditions
Comparison of Total Hemispherical Reflectance and Emittance Values Between Metformin Extended-Release Tablets Stored Under Ambient and Stress Conditions
Type 2 diabetes is a serious health problem worldwide. Metformin as the first-line drug in diabetes treatment mainly inhibits glucose production in the liver. Diabetes is often acc...
Formulation development and evaluation of osmotic drug delivery system for lornoxicam
Formulation development and evaluation of osmotic drug delivery system for lornoxicam
Osmotic systems are the most reliable controlled drug delivery systems and can be employed as oral drug delivery systems. Osmotic pressure is used as the driving force for these sy...
Update on biphasic anaphylaxis
Update on biphasic anaphylaxis
Purpose of review
Biphasic anaphylaxis is a well documented complication of anaphylaxis, but it has been inconsistently defined in the literature. Analysis of contempor...
Solubility enhancement of lornoxicam with poloxamer 188 by solvent evaporation method
Solubility enhancement of lornoxicam with poloxamer 188 by solvent evaporation method
This investigation aimed to enhance the solubility and bioavailability of the BCS class II poorly water-soluble drug Lornoxicam by solid dispersion (SD) techniques using Polaxomer ...
A unified approach to dissecting biphasic responses in cell signaling
A unified approach to dissecting biphasic responses in cell signaling
Biphasic responses are encountered at all levels in biological systems. At the cellular level, biphasic dose-responses are widely encountered in cell signaling and post-translation...
Biphasic responses in cell signalling: A unified approach
Biphasic responses in cell signalling: A unified approach
Abstract
Biphasic responses are encountered at all levels in biological systems. At the cellular level, biphasic dose-responses are widely encountered in cell signa...
Recent developments in orally disintegrating mini tablets
Recent developments in orally disintegrating mini tablets
Solid oral dosage forms are most suitable dosage forms; preferably tablets are widely accepted by people of different age groups. Mini tablets are tablets with a diameter equal to ...
Cefazolin Loaded Oxidized Regenerated Cellulose/Polycaprolactone Bilayered Composite for Use as Potential Antibacterial Dural Substitute
Cefazolin Loaded Oxidized Regenerated Cellulose/Polycaprolactone Bilayered Composite for Use as Potential Antibacterial Dural Substitute
Oxidized regenerated cellulose/polycaprolactone bilayered composite (ORC/PCL bilayered composite) was investigated for use as an antibacterial dural substitute. Cefazolin at the co...

